The B1-cell subpopulation is diminished in patients with relapsing-remitting multiple sclerosis

Journal of Neuroimmunology

Volumn 262, Issue 1-2, 2013, Pages 92-99

  Tørring, Caroline ^a,b   Petersen, Charlotte Christie ^b,c   Bjerg, Lasse ^b   Kofod Olsen, Emil ^b   Petersen, Thor ^a   Höllsberg, Per ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

B cells; B cell depleting antibodies; CD3+CD20+ cells; Human B1 cells; Relapsing remitting multiple sclerosis

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B1 CELL; CELL FRACTIONATION; CELL SELECTION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; MONOCYTE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL;

B CELLS; B-CELL-DEPLETING ANTIBODIES; CD3(+)CD20(+) CELLS; HUMAN B1 CELLS; RELAPSING-REMITTING MULTIPLE SCLEROSIS;

ADULT; ANTIGENS, CD20; ANTIGENS, CD3; B-LYMPHOCYTE SUBSETS; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; UP-REGULATION;

EID: 84884162413     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.06.002     Document Type: Article

References (31)

1. Bar-Or A., Fawaz L., Fan B., Darlington P.J., Rieger A., Ghorayeb C., Calabresi P.A., Waubant E., Hauser S.L., Zhang J., Smith C.H. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?. Ann. Neurol. 2010, 67:452-461.
2. Barun B., Bar-Or A. Treatment of multiple sclerosis with anti-CD20 antibodies. Clin. Immunol. 2012, 142:31-37.
3. Bjerg L., Brosbol-Ravnborg A., Torring C., Dige A., Bundgaard B., Petersen T., Hollsberg P. Altered frequency of T regulatory cells is associated with disability status in relapsing-remitting multiple sclerosis patients. J. Neuroimmunol. 2012, 249:76-82.
4. Chen L.C., Delgado J.C., Jensen P.E., Chen X. Direct expansion of human allospecific FoxP3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application. J. Immunol. 2009, 183:4094-4102.
5. Cross A.H., Stark J.L., Lauber J., Ramsbottom M.J., Lyons J.A. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 2006, 180:63-70.
6. Descatoire M., Weill J.C., Reynaud C.A., Weller S. A human equivalent of mouse B-1 cells?. J. Exp. Med. 2011, 208:2563-2564. (author reply 2566-2569).
7. Duddy M., Bar-Or A. B-cells in multiple sclerosis. Int. MS J. 2006, 13:84-90.
8. Duddy M., Niino M., Adatia F., Hebert S., Freedman M., Atkins H., Kim H.J., Bar-Or A. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 2007, 178:6092-6099.
9. Eisenberg R., Looney R.J. The therapeutic potential of anti-CD20 "what do B-cells do?". Clin. Immunol. 2005, 117:207-213.
10. Franciotta D., Salvetti M., Lolli F., Serafini B., Aloisi F. B cells and multiple sclerosis. Lancet Neurol. 2008, 7:852-858.
11. Good K.L., Avery D.T., Tangye S.G. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J. Immunol. 2009, 182:890-901.
12. Griffin D.O., Rothstein T.L. A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus. J. Exp. Med. 2011, 208:2591-2598.
13. Griffin D.O., Rothstein T.L. Human "orchestrator" CD11b(+) B1 cells spontaneously secrete IL-10 and regulate T cell activity. Mol. Med. 2012, 18:1003-1008.
14. Griffin D.O., Rothstein T.L. Human B1 cell frequency: isolation and analysis of human B1 cells. Front. Immunol. 2012, 3:122.
15. Griffin D.O., Holodick N.E., Rothstein T.L. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J. Exp. Med. 2011, 208:67-80.
16. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358:676-688.
17. Kawai K., Tsuno N.H., Matsuhashi M., Kitayama J., Osada T., Yamada J., Tsuchiya T., Yoneyama S., Watanabe T., Takahashi K., Nagawa H. CD11b-mediated migratory property of peripheral blood B cells. J. Allergy Clin. Immunol. 2005, 116:192-197.
18. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
19. Lassmann H., Bruck W., Lucchinetti C.F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007, 17:210-218.
20. Lucchinetti C.F., Popescu B.F., Bunyan R.F., Moll N.M., Roemer S.F., Lassmann H., Bruck W., Parisi J.E., Scheithauer B.W., Giannini C., Weigand S.D., Mandrekar J., Ransohoff R.M. Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 2011, 365:2188-2197.
21. Nagai A., Mishima S., Ishida Y., Ishikura H., Harada T., Kobayashi S., Kim S.U. Immortalized human microglial cell line: phenotypic expression. J. Neurosci. Res. 2005, 81:342-348.
22. Niino M., Hirotani M., Miyazaki Y., Sasaki H. Memory and naive B-cell subsets in patients with multiple sclerosis. Neurosci. Lett. 2009, 464:74-78.
23. Peelen E., Damoiseaux J., Smolders J., Knippenberg S., Menheere P., Tervaert J.W., Hupperts R., Thewissen M. Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse. J. Neuroimmunol. 2011, 240-241:97-103.
24. Perez-Andres M., Grosserichter-Wagener C., Teodosio C., van Dongen J.J., Orfao A., van Zelm M.C. The nature of circulating CD27+CD43+ B cells. J. Exp. Med. 2011, 208:2565-2566. (author reply 2566-2569).
25. Piccio L., Naismith R.T., Trinkaus K., Klein R.S., Parks B.J., Lyons J.A., Cross A.H. Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Arch. Neurol. 2010, 67:707-714.
26. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., Lublin F.D., Montalban X., O'Connor P., Sandberg-Wollheim M., Thompson A.J., Waubant E., Weinshenker B., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
27. Reynaud C.A., Weill J.C. Gene profiling of CD11b(+) and CD11b(-) B1 cell subsets reveals potential cell sorting artifacts. J. Exp. Med. 2012, 209:433-434. (author reply 434-436).
28. Whitmire J.K., Asano M.S., Kaech S.M., Sarkar S., Hannum L.G., Shlomchik M.J., Ahmed R. Requirement of B cells for generating CD4+ T cell memory. J. Immunol. 2009, 182:1868-1876.
29. Wilk E., Witte T., Marquardt N., Horvath T., Kalippke K., Scholz K., Wilke N., Schmidt R.E., Jacobs R. Depletion of functionally active CD20+ T cells by rituximab treatment. Arthritis Rheum. 2009, 60:3563-3571.
30. Williams K.C., Ulvestad E., Hickey W.F. Immunology of multiple sclerosis. Clin. Neurosci. 1994, 2:229-245.
31. Wilson H.L. B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms. Biologics 2012, 6:117-123.